Search

Author/Creator Horvath, Gabor

3. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study. (May 2017)

Authors:
Razavi, Homie; Robbins, Sarah; Zeuzem, Stefan; Negro, Francesco; Buti, Maria; Duberg, Ann-Sofi; Roudot-Thoraval, Françoise; Craxi, Antonio; Manns, Michael; Marinho, Rui T; Hunyady, Bela; Colombo, Massimo; Aleman, Soo; Antonov, Krasimir; Arkkila, Perttu; Athanasakis, Kostas; Blach, Sarah; Blachier...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 2:Number 5(2017)
Page Start:
325
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. IDDF2019-ABS-0210 Preliminary efficacy and safety of 8-week glecaprevir/pibrentasvir in patients with HCV genotype 1–6 infection and compensated cirrhosis: the EXPEDITION-8 study. (June 2019)

Authors:
Brown, Robert S; Hezode, Christopher; Wang, Stanley; Buti, Maria; Chuang, Wan-Long; Aguilar, Humberto; Horvath, Gabor; Carrion, Barbara Rosado; Rodriguez-Perez, Federico; Cohen, Eric; Hu, Yiran B; Schnell, Gretja; Lin, Chih-Wei; Rodrigues, Lino; Trinh, Roger; Mensa, Federico J
Journal:
Gut
Issue:
Volume 68(2019)Supplement 1
Page Start:
A146
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment‐naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II). Issue 7 (4th August 2015)

Authors:
Zeuzem, S.; Flisiak, R.; Vierling, J. M.; Mazur, W.; Mazzella, G.; Thongsawat, S.; Abdurakhmanov, D.; Van Kính, N.; Calistru, P.; Heo, J.; Stanciu, C.; Gould, M.; Makara, M.; Hsu, S.‐J.; Buggisch, P.; Samuel, D.; Mutimer, D.; Nault, B.; Merz, M.; Bao, W.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 42:Issue 7(2015)
Page Start:
829
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Randomized clinical trials towards a single‐visit cure for chronic hepatitis C: Oral GSK2878175 and injectable RG‐101 in chronic hepatitis C patients and long‐acting injectable GSK2878175 in healthy participants. Issue 7 (18th March 2020)

Authors:
Deng, Yanli; Campbell, Fiona; Han, Kelong; Theodore, Dickens; Deeg, Mark; Huang, Michael; Hamatake, Robert; Lahiri, Soumi; Chen, Shuguang; Horvath, Gabor; Manolakopoulos, Spilios; Dalekos, George N.; Papatheodoridis, George; Goulis, Ioannis; Banyai, Tivadar; Jilma, Bernd; Leivers, Martin
Journal:
Journal of viral hepatitis
Issue:
Volume 27:Issue 7(2020)
Page Start:
699
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗